216 related articles for article (PubMed ID: 2296310)
21. Human sickle hemoglobin in transgenic mice.
Ryan TM; Townes TM; Reilly MP; Asakura T; Palmiter RD; Brinster RL; Behringer RR
Science; 1990 Feb; 247(4942):566-8. PubMed ID: 2154033
[TBL] [Abstract][Full Text] [Related]
22. Long-term expression of gamma-globin mRNA in mouse erythrocytes from retrovirus vectors containing the human gamma-globin gene fused to the ankyrin-1 promoter.
Sabatino DE; Seidel NE; Aviles-Mendoza GJ; Cline AP; Anderson SM; Gallagher PG; Bodine DM
Proc Natl Acad Sci U S A; 2000 Nov; 97(24):13294-9. PubMed ID: 11069298
[TBL] [Abstract][Full Text] [Related]
23. A phase I/II clinical trial of beta-globin gene therapy for beta-thalassemia.
Bank A; Dorazio R; Leboulch P
Ann N Y Acad Sci; 2005; 1054():308-16. PubMed ID: 16339679
[TBL] [Abstract][Full Text] [Related]
24. A family study of HbS in a Malay family by molecular analysis.
Hafiza A; Noor HH; Noor FA; Azlin I; Ainoon O
Malays J Pathol; 2010 Dec; 32(2):137-41. PubMed ID: 21329186
[TBL] [Abstract][Full Text] [Related]
25. A human embryonic hemoglobin inhibits Hb S polymerization in vitro and restores a normal phenotype to mouse models of sickle cell disease.
He Z; Russell JE
Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10635-40. PubMed ID: 12124399
[TBL] [Abstract][Full Text] [Related]
26. High expression of human beta S- and alpha-globins in transgenic mice: hemoglobin composition and hematological consequences.
Fabry ME; Nagel RL; Pachnis A; Suzuka SM; Costantini F
Proc Natl Acad Sci U S A; 1992 Dec; 89(24):12150-4. PubMed ID: 1465454
[TBL] [Abstract][Full Text] [Related]
27. Hypoxia-induced in vivo sickling of transgenic mouse red cells.
Rubin EM; Witkowska HE; Spangler E; Curtin P; Lubin BH; Mohandas N; Clift SM
J Clin Invest; 1991 Feb; 87(2):639-47. PubMed ID: 1991848
[TBL] [Abstract][Full Text] [Related]
28. Magnetic resonance evidence of hypoxia in a homozygous alpha-knockout of a transgenic mouse model for sickle cell disease.
Fabry ME; Kennan RP; Paszty C; Costantini F; Rubin EM; Gore JC; Nagel RL
J Clin Invest; 1996 Dec; 98(11):2450-5. PubMed ID: 8958206
[TBL] [Abstract][Full Text] [Related]
29. Knockout-transgenic mouse model of sickle cell disease.
Ryan TM; Ciavatta DJ; Townes TM
Science; 1997 Oct; 278(5339):873-6. PubMed ID: 9346487
[TBL] [Abstract][Full Text] [Related]
30. Transgenic knockout mice with exclusively human sickle hemoglobin and sickle cell disease.
Pászty C; Brion CM; Manci E; Witkowska HE; Stevens ME; Mohandas N; Rubin EM
Science; 1997 Oct; 278(5339):876-8. PubMed ID: 9346488
[TBL] [Abstract][Full Text] [Related]
31. A second generation transgenic mouse model expressing both hemoglobin S (HbS) and HbS-Antilles results in increased phenotypic severity.
Fabry ME; Sengupta A; Suzuka SM; Costantini F; Rubin EM; Hofrichter J; Christoph G; Manci E; Culberson D; Factor SM; Nagel RL
Blood; 1995 Sep; 86(6):2419-28. PubMed ID: 7662990
[TBL] [Abstract][Full Text] [Related]
32. In vivo demonstration of red cell-endothelial interaction, sickling and altered microvascular response to oxygen in the sickle transgenic mouse.
Kaul DK; Fabry ME; Costantini F; Rubin EM; Nagel RL
J Clin Invest; 1995 Dec; 96(6):2845-53. PubMed ID: 8675655
[TBL] [Abstract][Full Text] [Related]
33. High expression of human beta S- and alpha-globins in transgenic mice: erythrocyte abnormalities, organ damage, and the effect of hypoxia.
Fabry ME; Costantini F; Pachnis A; Suzuka SM; Bank N; Aynedjian HS; Factor SM; Nagel RL
Proc Natl Acad Sci U S A; 1992 Dec; 89(24):12155-9. PubMed ID: 1465455
[TBL] [Abstract][Full Text] [Related]
34. Molecular genetics: mice, men and sickle cells.
Weatherall DJ
Nature; 1990 Jan; 343(6254):121. PubMed ID: 2296303
[No Abstract] [Full Text] [Related]
35. A recombinant human hemoglobin with anti-sickling properties greater than fetal hemoglobin.
Levasseur DN; Ryan TM; Reilly MP; McCune SL; Asakura T; Townes TM
J Biol Chem; 2004 Jun; 279(26):27518-24. PubMed ID: 15084588
[TBL] [Abstract][Full Text] [Related]
36. Towards a transgenic mouse model of sickle cell disease: hemoglobin SAD.
Trudel M; Saadane N; Garel MC; Bardakdjian-Michau J; Blouquit Y; Guerquin-Kern JL; Rouyer-Fessard P; Vidaud D; Pachnis A; Roméo PH
EMBO J; 1991 Nov; 10(11):3157-65. PubMed ID: 1915288
[TBL] [Abstract][Full Text] [Related]
37. Red blood cell membrane and density changes under ambient and hypoxic conditions in transgenic mice producing human sickle hemoglobin.
Reilly MP; Chomo MJ; Obata K; Asakura T
Exp Hematol; 1994 Jun; 22(6):501-9. PubMed ID: 8187846
[TBL] [Abstract][Full Text] [Related]
38. [Current trends in hemoglobin genetic diseases].
Girot R
Nouv Rev Fr Hematol (1978); 1991; 33(2):189-94. PubMed ID: 1766851
[TBL] [Abstract][Full Text] [Related]
39. Pathophysiology of a sickle cell trait mouse model: human alpha(beta)(S) transgenes with one mouse beta-globin allele.
Noguchi CT; Gladwin M; Diwan B; Merciris P; Smith R; Yu X; Buzard G; Fitzhugh A; Keefer LK; Schechter AN; Mohandas N
Blood Cells Mol Dis; 2001; 27(6):971-7. PubMed ID: 11831863
[TBL] [Abstract][Full Text] [Related]
40. [Sickle cell anemia].
Sugihara T
Nihon Rinsho; 1996 Sep; 54(9):2442-7. PubMed ID: 8890576
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
